Back to results
US 11,952,352 B2Granted
Ras inhibitors
AssigneeRevolution Medicines, Inc.
InventorsAdrian L. Gill, James Cregg, Elena S. Koltun, Yang Liu
Life of this patent
Estimating the term…
Abstract
The disclosure features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Claims4
A compound of the following structure:
- or a pharmaceutically acceptable salt thereof.
A compound of the following structure:
A pharmaceutical composition comprising a compound of the following structure:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
A pharmaceutical composition comprising a compound of the following structure:
- and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.